Increlex



Indications and Reactions:

Role Indications Reactions
Primary
Insulin-like Growth Factor Decreased 26.0%
Body Height Below Normal 11.9%
Product Used For Unknown Indication 11.7%
Growth Hormone Deficiency 10.7%
Primary Insulin Like Growth Factor-1 Deficiency 9.2%
Growth Retardation 5.6%
Off Label Use 4.4%
Failure To Thrive 3.4%
Rett's Disorder 2.9%
Convulsion 2.2%
Foetal Growth Restriction 1.9%
Blood Growth Hormone Abnormal 1.7%
Drug Use For Unknown Indication 1.7%
Insulin Resistance Syndrome 1.2%
Insulin-like Growth Factor Increased 1.2%
Autosomal Chromosome Anomaly 1.0%
Dwarfism 1.0%
Depression 0.7%
Ear Infection 0.7%
Hypopituitarism 0.7%
Urticaria 13.2%
Injection Site Urticaria 12.5%
Hypoglycaemia 7.6%
Tonsillar Hypertrophy 7.6%
Vomiting 6.9%
Headache 5.6%
Convulsion 4.9%
Papilloedema 4.9%
Blood Glucose Increased 3.5%
Hair Texture Abnormal 3.5%
Injection Site Swelling 3.5%
Loss Of Consciousness 3.5%
Osteonecrosis 3.5%
Aggression 2.8%
Alopecia 2.8%
Hydrocele 2.8%
Injection Site Pain 2.8%
Injection Site Pruritus 2.8%
Off Label Use 2.8%
Thyroid Neoplasm 2.8%
Secondary
Product Used For Unknown Indication 24.3%
Depression 20.9%
Primary Insulin Like Growth Factor-1 Deficiency 13.9%
Insulin-like Growth Factor Decreased 10.4%
Micturition Urgency 7.0%
Precocious Puberty 7.0%
Growth Hormone Deficiency 6.1%
Pyrexia 5.2%
Ear Infection 2.6%
Body Height Below Normal 0.9%
Dwarfism 0.9%
Insulin-like Growth Factor 0.9%
Encopresis 23.5%
Optic Nerve Disorder 14.7%
Thyroid Neoplasm 14.7%
Tonsillar Hypertrophy 8.8%
Urticaria 8.8%
Constipation 5.9%
Volvulus Of Small Bowel 5.9%
Abdominal Pain 2.9%
Fatigue 2.9%
Headache 2.9%
Injection Site Urticaria 2.9%
Ocular Hyperaemia 2.9%
Thrombocytopenia 2.9%
Concomitant
Growth Retardation 33.3%
Foetal Growth Restriction 22.2%
Growth Hormone Deficiency 22.2%
Product Used For Unknown Indication 22.2%
Chronic Myelomonocytic Leukaemia 37.5%
Dysplasia 25.0%
Fibroma 12.5%
Implant Site Papules 12.5%
Jaw Disorder 12.5%